Literature DB >> 19371993

[Spanish asthma patients' beliefs about health and medicines: validation of 2 questionnaires].

Miguel Perpiñá Tordera1, Eva Martínez Moragón, Amparo Belloch Fuster, Amparo Lloris Bayo, Concepción Pellicer Císcar.   

Abstract

OBJECTIVE: We translated 2 health beliefs questionnaires-an instrument based on the health belief model (HBM) containing 19 items in 6 domains and the Beliefs About Medicines Questionnaire (BMQ) containing 18 items divided into a general and a specific section-and then administered and validated them in a group of Spanish patients with asthma. PATIENTS AND METHODS: In 2 clinical visits data were collected on 126 patients with stable asthma of different levels of severity. At the first visit, the patients underwent spirometry and were asked questions about sociodemographic factors and clinical history. At the second visit, they completed the State-Trait Anxiety Inventory, the Beck Depression Inventory, and the Spanish versions of the HBM and BMQ, which had been previously translated and backtranslated.
RESULTS: The BMQ had adequate internal consistency and content validity but the HBM replicated just 4 of the 6 domains present in the original questionnaire. The reformulated HBM (measuring 4 domains) accounted for 48% of the variance and had Cronbach #a levels ranging from 0.63 to 0.75. The 2 questionnaires showed interactions between a) negative beliefs about medicines and asthma and b) awareness of the need for medication and trust in physician and pessimism. Correlations were also found between negative beliefs and anxiety and depression and between awareness of the need for medication and disease severity. Finally, low educational level, female sex, and greater duration of asthma were correlated with beliefs that disease control was driven by chance.
CONCLUSIONS: The reformulated HBM and the BMQ have satisfactory measurement properties and assess similar but not identical aspects of beliefs and value judgments about health and medicine in individuals with asthma. These beliefs were correlated to different degrees with the clinical, sociodemographic, and psychologic variables studied.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19371993     DOI: 10.1016/j.arbres.2008.06.006

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN: 0300-2896            Impact factor:   4.872


  6 in total

1.  Cross-cultural Adaptation and Validation of Beliefs about Medicines Questionnaire on Asthma and Chronic Obstructive Pulmonary Disease Patients.

Authors:  Hüseyin Arıkan; Dildar Duman; Feyza Kargın; Gülbin Ergin; Rob Horne; Sait Karakurt; Emel Eryüksel
Journal:  Turk Thorac J       Date:  2018-01-03

2.  Evaluating the Validity and Reliability of the Beliefs About Medicines Questionnaire in Low-Income, Spanish-Speaking Patients With Diabetes in the United States.

Authors:  Krystal Jimenez; Cristina Vargas; Karla Garcia; Herlinda Guzman; Marco Angulo; John Billimek
Journal:  Diabetes Educ       Date:  2016-11-10       Impact factor: 2.140

3.  Theory based health education: Application of health belief model for Iranian patients with myocardial infarction.

Authors:  Shervin Assari
Journal:  J Res Med Sci       Date:  2011-04       Impact factor: 1.852

4.  A structural equation model of relationships of health literacy, illness and medication beliefs with medication adherence among patients with chronic obstructive pulmonary disease.

Authors:  Parul Agarwal; Jenny Lin; Kimberly Muellers; Rachel O'Conor; Michael Wolf; Alex D Federman; Juan P Wisnivesky
Journal:  Patient Educ Couns       Date:  2020-11-25

5.  Psychometric properties of the Belief about Medicines Questionnaire (BMQ) in the Maltese language.

Authors:  Ingrid Gatt; Lorna M West; Neville Calleja; Charles Briffa; Maria Cordina
Journal:  Pharm Pract (Granada)       Date:  2017-03-15

6.  The Association of Health Literacy with Illness and Medication Beliefs among Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Minal S Kale; Alex D Federman; Katherine Krauskopf; Michael Wolf; Rachel O'Conor; Melissa Martynenko; Howard Leventhal; Juan P Wisnivesky
Journal:  PLoS One       Date:  2015-04-27       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.